Elesclomol
id:
elesclomol-265-12942005
title:
Elesclomol
text:
Elesclomol is a drug that triggers apoptosis in cancer cells. It is being developed by Synta Pharmaceuticals and GlaxoSmithKline as a chemotherapy adjuvant, and has received both fast track and orphan drug status from the U.S. Food and Drug Administration for the treatment of metastatic melanoma. Synta Pharmaceuticals announced on February 26, 2009 the suspension of all clinical trials involving Elesclomol due to safety concerns. In March 2010, Synta announced that the FDA had approved resuming
brand slug:
wiki
category slug:
encyclopedia
description:
Chemical compound
original url:
https://en.wikipedia.org/wiki/Elesclomol
date created:
date modified:
2023-09-08T04:21:48Z
main entity:
{"identifier":"Q5359460","url":"https://www.wikidata.org/entity/Q5359460"}
image:
{"content_url":"https://upload.wikimedia.org/wikipedia/commons/7/78/Elesclomol-3D-spacefill.png","width":2603,"height":1000}
fields total:
13
integrity:
15